Incyte sec filings

WebThis page has all the financial reports filed by INCYTE CORP including the common sec filings such as Annual reports 10K, Quarterly reports 10Q, Insider trading reports on Form … WebApr 15, 2024 · Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.34% of Incyte worth $59,867,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Pacer Advisors Inc. Sells 7,945 Shares of Incyte Co. (NASDAQ:INCY)

WebOct 25, 2024 · Incyte gains exclusive, worldwide development and commercialization rights to MGA012 in all indications; ... the availability or commercial potential of MacroGenics' product candidates and other risks described in MacroGenics' filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press ... WebApr 11, 2024 · Exchange Traded Concepts LLC decreased its position in Incyte Co. (NASDAQ:INCY - Get Rating) by 7.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 25,291 shares of the biopharmaceutical company's stock after selling 2,039 shares during the q small starcraft campers https://thethrivingoffice.com

Incyte Corp (INCY) 10-K Annual Report February 2024

WebJan 9, 2024 · All companies, foreign and domestic, are required to file registration statements, periodic reports, and other forms electronically through EDGAR. WebIncyte Corp. SEC filings breakout by MarketWatch. View the INCY U.S. Securities and Exchange Commission reporting information. Skip to main contentMain Menu Home … WebJan 9, 2024 · WILMINGTON, D.E. & KENILWORTH, N.J. – Incyte Corporation (Nasdaq:INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the decision to advance the clinical development program investigating the combination of epacadostat, Incyte’s investigational oral selective IDO1 inhibitor, with … small starfish clip art

Peggy Scherle, Ph.D. - Prelude Therapeutics

Category:Syndax Pharmaceuticals and Incyte Announce Global …

Tags:Incyte sec filings

Incyte sec filings

Incyte Co. (NASDAQ:INCY) Shares Sold by Greenwood Capital …

WebIncyte Corp. Annual stock financials by MarketWatch. View the latest INCY financial statements, income statements and financial ratios. WebApr 13, 2024 · The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Maria E. Pasquale sold 60,024 shares of Incyte stock in a transaction that occurred on Monday, January 30th. The stock was sold at an average price of $84.74, for a total value of $5,086,433.76.

Incyte sec filings

Did you know?

WebApr 6, 2024 · Incyte Corp. – Filings and Transcripts – BamSEC Incyte Corp. Watch NASDAQ: INCY Share price (3/29/23): $71.14 Market cap (3/29/23): $15.9 billion 8 Incyte Corp. Expert Interviews, now on BamSEC. Powered by Tegus. See All INCY Interviews Financials Filter 10-K ended 12/31/22 FY 2024 02/07/23 10-Q ended 09/30/22 Q3 11/01/22 10-Q ended … WebApr 11, 2024 · State of Michigan Retirement System raised its stake in shares of Incyte Co. ( NASDAQ:INCY – Get Rating) by 0.4% during the fourth quarter, according to its most recent 13F filing with the...

WebApr 13, 2024 · China Universal Asset Management Co. Ltd. lifted its stake in Incyte Co. ( NASDAQ:INCY – Get Rating) by 8.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. WebApr 4, 2024 · Pacer Advisors Inc. decreased its position in Incyte Co. (NASDAQ:INCY - Get Rating) by 92.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 666 shares of the biopharmaceutical company's stock after selling 7,945 shares during the quart

WebIncyte Corp. SEC filings breakout by MarketWatch. View the INCY U.S. Securities and Exchange Commission reporting information. Skip to main contentMain Menu Home Latest News Watchlist...

WebSEC Filings Incyte Corp (INCY) 10-K Annual Report Tue Feb 07 2024 10-Q Quarterly Report May 2024 10-Q Quarterly Report November 2024 10-Q Quarterly Report August 2024 10-Q …

WebScherle was one of the original team of scientists that joined Incyte in 2002 and was involved in the discovery and development of the JAK inhibitors, Jakafi® (ruxolitinib), for the treatment of myelofibrosis and polycythemia vera, and Olumiant® (baricitinib), for rheumatoid arthritis, as well as the advancement of >10 small molecules into … small starfish lampWebFeb 8, 2024 · Incyte Corp (INCY) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024 Home SEC Filings Incyte Corp (INCY) 10-K Annual Report Tue … small starfish tattooWebFind the latest SEC Filings data for Incyte Corp. Common Stock (INCY) at Nasdaq.com. small starfish earringsWebApr 5, 2024 · INCY traded up $1.14 on Wednesday, hitting $73.79. 266,480 shares of the company's stock were exchanged, compared to its average volume of 1,653,264. The company has a current ratio of 3.54, a quick ratio of 3.50 and a debt-to-equity ratio of 0.01. The stock has a fifty day moving average of $77.16 and a two-hundred day moving … highway authority permitted developmentWebIncyte Corp. SEC filings breakout by MarketWatch. View the INCY U.S. Securities and Exchange Commission reporting information. small starfish imagesWebNov 1, 2024 · Incyte Corp (INCY) SEC Filing 8-K Material Event for the period ending Tuesday, November 1, 2024 highway authority statutory dutiesWebApr 15, 2024 · International Biotechnology Trust PLC lowered its stake in Incyte Co. (NASDAQ:INCY - Get Rating) by 20.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 229,000 shares of the biopharmaceutical company's stock after selling 60,000 shares during the period. Incyt small starfleet ships